Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Status:
Terminated
Trial end date:
2017-04-30
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate the efficacy, safety and tolerability of a
therapeutic course of Eurartesim® in travellers who contracted malaria due to infection by P.
vivax in endemic countries.